ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.
Oncol Rep. 2022 Feb;47(2):23. doi: 10.3892/or.2021.8234. Epub 2021 Nov 29.
Oncol Rep. 2022.
PMID: 34841437
Free PMC article.